State Directory
Provider Records in Georgia
GLP1Search tracks 406 provider records across 85 Georgia cities. 10 records include explicit GLP-1, medication, or peptide treatment evidence; 396 are directory-only healthcare/provider records that need direct confirmation.
Provider Records
406
Cities
85
Treatment Evidence
10
Directory-Only
396
Market Snapshot
Where source-ready GLP-1 records are concentrated in Georgia
The Georgia source-ready local index is led by Atlanta. Across the state, 97% of provider records include phone plus address or website coverage, 22% list public pricing, and 42% carry an upstream source/place signal.
Data Complete
97%
Pricing Visible
22%
Source Flagged
42%
Treatment-Specific Directories
Medication and peptide location pages for Georgia
These pages focus on high-intent treatment searches where the state has enough listing density to support a useful directory page.
Top Georgia cities for source-ready GLP-1 records
Featured provider records in Georgia
Atlanta Men's ClinicAtlanta · $500+Semaglutide evidence, Tirzepatide evidenceRenew Vitality Testosterone Clinic of AtlantaAtlanta · $500+Semaglutide evidence, Tirzepatide evidenceDr. Weight Loss of Atlanta - BuckheadAtlanta · $500+Semaglutide evidence, Tirzepatide evidenceDr. Weight Loss of Atlanta - Inman ParkAtlanta · $500+Semaglutide evidence, Tirzepatide evidenceDr. Weight Loss of Atlanta - Sandy SpringsAtlanta · $500+Semaglutide evidence, Tirzepatide evidence
All covered cities in Georgia
Questions about provider records in Georgia
How many providers are listed?
GLP1Search lists 406 provider records across 85 cities in Georgia, including 10 treatment-evidence records and 396 directory-only records to verify.
Which cities have the most listings?
Atlanta (131), Marietta (22), Columbus (21), Alpharetta (17), Decatur (12) currently have the highest listing density in Georgia.
What should patients compare?
Compare licensed clinical oversight, medication source, pharmacy type, public pricing, follow-up cadence, side-effect support, and whether the clinic documents semaglutide or tirzepatide availability.